LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 21 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $422,000 | +20.2% | 113,500 | 0.0% | 0.01% | +33.3% |
Q2 2022 | $351,000 | -42.1% | 113,500 | 0.0% | 0.01% | -40.0% |
Q1 2022 | $606,000 | +9.4% | 113,500 | 0.0% | 0.01% | +42.9% |
Q4 2021 | $554,000 | -44.8% | 113,500 | 0.0% | 0.01% | -36.4% |
Q3 2021 | $1,004,000 | -3.0% | 113,500 | 0.0% | 0.01% | +10.0% |
Q2 2021 | $1,035,000 | -78.9% | 113,500 | -62.2% | 0.01% | -78.3% |
Q1 2021 | $4,914,000 | – | 300,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,321,403 | $20,869,000 | 0.71% |
Integral Health Asset Management, LLC | 30,000 | $274,000 | 0.08% |
FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $7,392,000 | 0.03% |
Orbimed Advisors | 113,500 | $1,035,000 | 0.01% |
Alyeska Investment Group, L.P. | 85,360 | $778,000 | 0.01% |
PRICE T ROWE ASSOCIATES INC /MD/ | 2,287,289 | $20,105,000 | 0.00% |
Laurion Capital Management LP | 20,918 | $191,000 | 0.00% |
FMR LLC | 2,037,831 | $18,585,000 | 0.00% |
BlackRock Inc. | 17,999 | $164,000 | 0.00% |
Tower Research Capital LLC (TRC) | 38 | $0 | 0.00% |